LU502953B1 - A formula for treating cardiovascular and cerebrovascular diseases and preparation method thereof - Google Patents

A formula for treating cardiovascular and cerebrovascular diseases and preparation method thereof Download PDF

Info

Publication number
LU502953B1
LU502953B1 LU502953A LU502953A LU502953B1 LU 502953 B1 LU502953 B1 LU 502953B1 LU 502953 A LU502953 A LU 502953A LU 502953 A LU502953 A LU 502953A LU 502953 B1 LU502953 B1 LU 502953B1
Authority
LU
Luxembourg
Prior art keywords
parts
formula
shell
tortoises
centipede
Prior art date
Application number
LU502953A
Other languages
German (de)
Inventor
Baoliang Chen
Original Assignee
Baoliang Chen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baoliang Chen filed Critical Baoliang Chen
Priority to LU502953A priority Critical patent/LU502953B1/en
Application granted granted Critical
Publication of LU502953B1 publication Critical patent/LU502953B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/58—Reptiles
    • A61K35/586—Turtles; Tortoises, e.g. terrapins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/648—Myriapods, e.g. centipedes or millipedes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/285—Aucklandia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A61K36/296—Epimedium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A61K36/428—Trichosanthes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/50—Fumariaceae (Fumitory family), e.g. bleeding heart
    • A61K36/505—Corydalis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/536—Prunella or Brunella (selfheal)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/64—Orobanchaceae (Broom-rape family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A61K36/8988—Gastrodia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a formula for treating cardiovascular and cerebrovascular diseases, including the following ingredients in parts by weight: 8-20 parts of ginseng, 15-60 parts of astragalus, 8-15 parts of atractylodes, 8-15 parts of poria, 15-30 parts of cistanche, 8-20 parts of epimedium, 8-15 parts of rehmannia, 10-30 parts of tortoises shell, 8-25 parts of turtle shell, 8-30 parts of concha haliotidis, 8-20 parts of prunella vulgaris, 1-5 parts of resina draconis, 6-15 parts of rhizoma corydalis, 3-10 parts of olibanum, 3-10 parts of myrrha, 8-20 parts of chuanxiong rhizome, 8-15 parts of panax notoginseng, 2-8 parts of scorpion, 8-15 parts of lumbricus, 2-5 parts of centipede, 8-20 parts of bombyx batryticatus, 8-25 parts of seaweed, 6-20 parts of fructus trichosanthis, 10-30 parts of rhizoma cyperi, 5-10 parts of radix aucklandiae, 8-25 parts of uncaria, 8-15 parts of gastrodia elata, 8-15 parts of angelica sinensis, 8-15 parts of taxillus chinensis, 8-30 parts of millettia dielsiana, the invention has strong functionality and can be widely used in the technical field of traditional Chinese medicine preparation.

Description

BL-5579
A FORMULA FOR TREATING CARDIOVASCULAR AND CEREBROVASCULARU502953
DISEASES AND PREPARATION METHOD THEREOF
FIELD OF THE INVENTION
The invention relates to the field of traditional Chinese medicine preparation, and specifically refers to a formula for treating cardiovascular and cerebrovascular diseases and preparation method thereof.
BACKGROUND OF THE RELATED ART
Cardio-cerebrovascular disease is a common and frequently-occurring disease among middle- aged and elderly people. Patients often show symptoms such as hypertension, coronary heart disease, cerebrovascular sclerosis, and insufficient blood supply to the brain, which will seriously affect the patient's ability to take care of him/herself, which brings certain economic and labor burdens to patients and their families. The treatment methods and auxiliary treatment methods in the prior art are generally combination of Chinese medicine, western medicine, surgery and vascular irrigation, etc., however, the disadvantages of these methods are that they cannot achieve the purpose of relieving or curing under the condition of easy acceptance by the patients, especially for long-term treatment patients, which is even a psychological burden.
SUMMARY OF THE INVENTION
In view of the above problems, the present invention proposes a formula for treating cardiovascular and cerebrovascular diseases, which will not cause the patient to develop drug resistance during the use process, and can achieve the purpose of curing.
The technical solutions provided by the present invention are: a formula for treating cardiovascular and cerebrovascular diseases, it comprises the following ingredients in parts by weight: 8-20 parts of ginseng, 15-60 parts of astragalus, 8-15 parts of atractylodes, 8-15 parts of poria, 15-30 parts of cistanche, 8-20 parts of epimedium, 8-15 parts of rehmannia, 10-30 parts of tortoises shell, 8-25 parts of turtle shell, 8-30 parts of concha haliotidis, 8- parts of prunella vulgaris, 1-5 parts of resina draconis, 6-15 parts of rhizoma corydalis, 3-10 parts of olibanum, 3-10 parts of myrrha, 8-20 parts of chuanxiong rhizome, 8-15 parts of panax notoginseng, 1
BL-5579 2-8 parts of scorpion, 8-15 parts of lumbricus, 2-5 parts of centipede, 8-20 parts of boml502953 batryticatus, 8-25 parts of seaweed, 6-20 parts of fructus trichosanthis, 10-30 parts of rhizoma cyperi, 5-10 parts of radix aucklandiae, 8-25 parts of uncaria, 8-15 parts of gastrodia elata, 8-15 parts of angelica sinensis, 8-15 parts of taxillus chinensis, 8-30 parts of millettia dielsiana.
Further, it comprises the following ingredients in parts by weight: 8 parts of ginseng, 15 parts of astragalus, 8 parts of atractylodes, 8 parts of poria, 15 parts of cistanche, 8 parts of epimedium, 8 parts of rehmannia, 10 parts of tortoises shell, 8 parts of turtle shell, 8 parts of concha haliotidis, 8 parts of prunella vulgaris, 1 part of resina draconis, 6 parts of rhizoma corydalis, 3 parts of olibanum, 3 parts of myrrha, 8 parts of chuanxiong rhizome, 8 parts of panax notoginseng, 2 parts of scorpion, 8 parts of lumbricus, 2 parts of centipede, 8 parts of bombyx batryticatus, 8 parts of seaweed, 6 parts of fructus trichosanthis, 10 parts of rhizoma cyperi, 5 parts of radix aucklandiae, 8 parts of uncaria, 8 parts of gastrodia elata, 8 parts of angelica sinensis, 8 parts of taxillus chinensis, 8 parts of millettia dielsiana.
Further, it comprises the following ingredients in parts by weight: 20 parts of ginseng, 60 parts of astragalus, 15 parts of atractylodes, 15 parts of poria, 30 parts of cistanche, 20 parts of epimedium, 15 parts of rehmannia, 30 parts of tortoises shell, 25 parts of turtle shell, 30 parts of concha haliotidis, 20 parts of prunella vulgaris, 5 parts of resina draconis, 15 parts of rhizoma corydalis, 10 parts of olibanum, 10 parts of myrrha, 20 parts of chuanxiong rhizome, 15 parts of panax notoginseng, 8 parts of scorpion, 15 parts of lumbricus, 5 parts of centipede, 20 parts of bombyx batryticatus, 25 parts of seaweed, 20 parts of fructus trichosanthis, 30 parts of rhizoma cyperi, 10 parts of radix aucklandiae, parts of uncaria, 15 parts of gastrodia elata, 15 parts of angelica sinensis, 15 parts of taxillus chinensis, 30 parts of millettia dielsiana.
Further, it comprises the following ingredients in parts by weight: 14 parts of ginseng, 35 parts of astragalus, 12 parts of atractylodes, 12 parts of poria, 22 parts of cistanche, 14 parts of epimedium, 11 parts of rehmannia, 20 parts of tortoises shell, 13 parts of turtle shell, 19 parts of concha haliotidis, 14 parts of prunella vulgaris, 3 parts of resina draconis, 11 parts of rhizoma corydalis, 6.5 parts of olibanum, 6.5 parts of myrrha, 14 parts of chuanxiong rhizome, 11 parts of panax notoginseng, 5 parts of scorpion, 11 parts of lumbricus, 3.5 parts of centipede, 14 parts of bombyx batryticatus, 11 parts of seaweed, 13 parts of fructus trichosanthis, 20 parts of rhizoma cyperi, 7.5 parts of radix aucklandiae, 13 parts of uncaria, 13 parts of gastrodia elata, 12 parts of angelica sinensis, 13 parts of taxillus chinensis, 19 parts of millettia dielsiana. 2
BL-5579
The present invention also provides a technical solution: LU502953
A preparation method of a formula for treating cardiovascular and cerebrovascular diseases, the formula being the above-mentioned formula and including the following preparation process: take a certain amount of ginseng, astragalus, atractylodes, poria, cistanche, epimedium, rehmannia, tortoises shell, turtle shell, concha haliotidis, prunella vulgaris, resina draconis, rhizoma corydalis, olibanum, myrrha, chuanxiong rhizome, panax notoginseng, scorpion, lumbricus, centipede, bombyx batryticatus, seaweed, fructus trichosanthis, rhizoma cyperi, radix aucklandiae, uncaria, gastrodia elata, angelica sinensis, taxillus chinensis, and millettia dielsiana are mixed, then use grinding equipment to grind them into a certain fineness of powder, and then add honey and mix to make pills.
Further, the grinding fineness of the powder is 50-100 mesh.
The advantages of the present invention compared with the prior art are: by adopting the formula provided by the present invention, not only the purpose of curing cardiovascular and cerebrovascular diseases is achieved, but the patient will not develop drug- resistant psychology, and the function is strong; the technology provided by the invention is convenient to take medicine, can realize the function of taking the medicine alone for patients of different ages, reduces the nursing burden, and has stronger practicability.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
The present invention will be further described in detail below in conjunction with embodiments.
The formula for treating cardiovascular and cerebrovascular diseases provided by the present invention includes the following ingredients in parts by weight: 8-20 parts of ginseng, 15-60 parts of astragalus, 8-15 parts of atractylodes, 8-15 parts of poria, 15-30 parts of cistanche, 8-20 parts of epimedium, 8-15 parts of rehmannia, 10-30 parts of tortoises shell, 8-25 parts of turtle shell, 8-30 parts of concha haliotidis, 8-20 parts of prunella vulgaris, 1-5 parts of resina draconis, 6-15 parts of rhizoma corydalis, 3-10 parts of olibanum, 3-10 parts of myrrha, 8-20 parts of chuanxiong rhizome, 8-15 parts of panax notoginseng, 2-8 parts of scorpion, 8- parts of lumbricus, 2-5 parts of centipede, 8-20 parts of bombyx batryticatus, 8-25 parts of seaweed, 6-20 parts of fructus trichosanthis, 10-30 parts of rhizoma cyperi, 5-10 parts of radix 3
BL-5579 aucklandiae, 8-25 parts of uncaria, 8-15 parts of gastrodia elata, 8-15 parts of angelica sinensis 8508953 parts of taxillus chinensis, 8-30 parts of millettia dielsiana.
The process of using the above formula to make medicines includes the following processes: take a certain amount of ginseng, astragalus, atractylodes, poria, cistanche, epimedium, rehmannia, tortoises shell, turtle shell, concha haliotidis, prunella vulgaris, resina draconis, rhizoma corydalis, olibanum, myrrha, chuanxiong rhizome, panax notoginseng, scorpion, lumbricus, centipede, bombyx batryticatus, seaweed, fructus trichosanthis, rhizoma cyperi, radix aucklandiae, uncaria, gastrodia elata, angelica sinensis, taxillus chinensis, and millettia dielsiana are mixed, then use grinding equipment to grind them into a certain fineness of powder, and then add honey and mix to make pills.
In the specific preparation process, in order to improve the medicine effect, tortoises shell, turtle shell, scorpion, centipede, bombyx batryticatus, olibanum, and myrrha can be processed. In addition, the millettia dielsiana is boiled into a paste and added to other ingredients, and the preparation process is implemented by adding honey to make pills.
By adopting the method provided by the invention for the preparation of the medicine, the realization of the pill medicine is achieved, and then it is applied to the treatment process of cardiovascular and cerebrovascular diseases, which is more convenient for patients to take.
Embodiment 1
A formula for treating cardiovascular and cerebrovascular diseases, it comprises the following ingredients in parts by weight: 8 parts of ginseng, 15 parts of astragalus, 8 parts of atractylodes, 8 parts of poria, 15 parts of cistanche, 8 parts of epimedium, 8 parts of rehmannia, 10 parts of tortoises shell, 8 parts of turtle shell, 8 parts of concha haliotidis, 8 parts of prunella vulgaris, 1 part of resina draconis, 6 parts of rhizoma corydalis, 3 parts of olibanum, 3 parts of myrrha, 8 parts of chuanxiong rhizome, 8 parts of panax notoginseng, 2 parts of scorpion, 8 parts of lumbricus, 2 parts of centipede, 8 parts of bombyx batryticatus, 8 parts of seaweed, 6 parts of fructus trichosanthis, 10 parts of rhizoma cyperi, 5 parts of radix aucklandiae, 8 parts of uncaria, 8 parts of gastrodia elata, 8 parts of angelica sinensis, 8 parts of taxillus chinensis, 8 parts of millettia dielsiana.
In the process of preparing medicines for treating cardiovascular and cerebrovascular diseases by using the above-mentioned ingredients, the following operation process is adopted: take a certain amount of ginseng, astragalus, atractylodes, poria, cistanche, epimedium, 4
BL-5579 rehmannia, tortoises shell, turtle shell, concha haliotidis, prunella vulgaris, resina draconis, rhitdg02953 corydalis, olibanum, myrrha, chuanxiong rhizome, panax notoginseng, scorpion, lumbricus, centipede, bombyx batryticatus, seaweed, fructus trichosanthis, rhizoma cyperi, radix aucklandiae, uncaria, gastrodia elata, angelica sinensis, taxillus chinensis, and millettia dielsiana are mixed, then use grinding equipment to grind them into 50 mesh powder, and then add honey and mix to make pills.
Embodiment 2
A formula for treating cardiovascular and cerebrovascular diseases, it comprises the following ingredients in parts by weight: 20 parts of ginseng, 60 parts of astragalus, 15 parts of atractylodes, 15 parts of poria, 30 parts of cistanche, 20 parts of epimedium, 15 parts of rehmannia, 30 parts of tortoises shell, 25 parts of turtle shell, 30 parts of concha haliotidis, 20 parts of prunella vulgaris, 5 parts of resina draconis, 15 parts of rhizoma corydalis, 10 parts of olibanum, 10 parts of myrrha, 20 parts of chuanxiong rhizome, 15 parts of panax notoginseng, 8 parts of scorpion, 15 parts of lumbricus, 5 parts of centipede, 20 parts of bombyx batryticatus, 25 parts of seaweed, 20 parts of fructus trichosanthis, 30 parts of rhizoma cyperi, 10 parts of radix aucklandiae, 25 parts of uncaria, 15 parts of gastrodia elata, 15 parts of angelica sinensis, 15 parts of taxillus chinensis, 30 parts of millettia dielsiana.
The preparation process is the same as in embodiment 1, but the fineness of the ground powder is 100 mesh.
Embodiment 3
A formula for treating cardiovascular and cerebrovascular diseases, it comprises the following ingredients in parts by weight: 14 parts of ginseng, 35 parts of astragalus, 12 parts of atractylodes, 12 parts of poria, 22 parts of cistanche, 14 parts of epimedium, 11 parts of rehmannia, 20 parts of tortoises shell, 13 parts of turtle shell, 19 parts of concha haliotidis, 14 parts of prunella vulgaris, 3 parts of resina draconis, 11 parts of rhizoma corydalis, 6.5 parts of olibanum, 6.5 parts of myrrha, 14 parts of chuanxiong rhizome, 11 parts of panax notoginseng, 5 parts of scorpion, 11 parts of lumbricus, 3.5 parts of centipede, 14 parts of bombyx batryticatus, 11 parts of seaweed, 13 parts of fructus trichosanthis, 20 parts of rhizoma cyperi, 7.5 parts of radix aucklandiae, 13 parts of uncaria, 13 parts of gastrodia elata, 12 parts of angelica sinensis, 13 parts of taxillus chinensis, 19 parts of millettia dielsiana.
BL-5579
The preparation process is the same as in embodiment 1. LU502953
Embodiment 4
In this embodiment, the treatment effects of the first to third embodiment are verified.
First of all, due to the unique characteristics of the preparation process of the present invention, the prepared medicine can maintain its original medicinal properties and is more convenient for patients to take.
Then, the technology provided by the present invention is divided into four categories for verification.
Category 1:
Patients with clinical hypertension in the three age groups of 50, 60, and 70 were selected as clinical experiment subjects, and each age group was 10 people, and they were divided into experimental group and control group, the experimental group took the formula provided by the present invention, and the control group took the common antihypertensive medicine in the prior art.
After three months of observation, it is found that taking the medicine provided by the present invention can achieve a greater degree of relief function, patients with mild hypertension have been cured, and the patients are easier to accept during the process of taking, thereby improving the treatment efficiency. However, in the control group, the treatment effect was not obvious due to the difficulty of taking the medicine and the poor medicinal properties, and the cost of the treatment was increased.
Category 2:
Patients with clinical coronary heart disease in the three age groups of 50, 60, and 70 were selected as clinical experiment subjects, and each age group was 10 people, and they were divided into experimental group and control group, the experimental group took the formula provided by the present invention, and the control group took the common medicine in the prior art.
After four months of observation, it is found that taking the medicine provided by the present invention can achieve a greater degree of relief function, patients with mild coronary heart disease have been cured, and the patients are easier to accept during the process of taking, thereby improving the treatment efficiency. However, in the control group, the treatment effect was not obvious due to the difficulty of taking the medicine and the poor medicinal properties, and the cost of the treatment was increased. 6
BL-5579
Category 3: LU502953
Patients with clinical cerebrovascular sclerosis and insufficient blood supply to the brain in the three age groups of 50, 60, and 70 were selected as clinical experiment subjects, and each age group was 10 people, and they were divided into experimental group and control group, the experimental group took the formula provided by the present invention, and the control group took the common medicine in the prior art.
After four months of observation, it is found that taking the medicine provided by the present invention can achieve a greater degree of relief function, patients with mild diseases have been cured, and the patients are easier to accept during the process of taking, thereby improving the treatment efficiency. However, in the control group, the treatment effect was not obvious due to the difficulty of taking the medicine and the poor medicinal properties, and the cost of the treatment was increased.
In summary, by adopting the formula provided by the present invention, the purpose of treating hypertension, coronary heart disease, cerebrovascular sclerosis and cerebral blood supply can be achieved, with strong functionality and wide application range.
The present invention and the embodiments have been described above. This description is not restrictive. What is shown in the embodiments is only one of the implementation manners of the present invention, and the actual content of the invention is not limited thereto. All in all, if a person of ordinary skill in the art is inspired by it, without departing from the inventive purpose of the present invention, without creatively designing structural methods and embodiments similar to the technical solution, it should fall within the protection scope of the present invention. 7

Claims (6)

BL-5579 CLAIMS LU502953
1. A formula for treating cardiovascular and cerebrovascular diseases, which is characterized in that, it comprises the following ingredients in parts by weight: 8-20 parts of ginseng, 15-60 parts of astragalus, 8-15 parts of atractylodes, 8-15 parts of poria, 15-30 parts of cistanche, 8-20 parts of epimedium, 8-15 parts of rehmannia, 10-30 parts of tortoises shell, 8-25 parts of turtle shell, 8-30 parts of concha haliotidis, 8-20 parts of prunella vulgaris, 1-5 parts of resina draconis, 6-15 parts of rhizoma corydalis, 3-10 parts of olibanum, 3-10 parts of myrrha, 8-20 parts of chuanxiong rhizome, 8-15 parts of panax notoginseng, 2-8 parts of scorpion, 8-15 parts of lumbricus, 2-5 parts of centipede, 8-20 parts of bombyx batryticatus, 8-25 parts of seaweed, 6-20 parts of fructus trichosanthis, 10-30 parts of rhizoma cyperi, 5-10 parts of radix aucklandiae, 8-25 parts of uncaria, 8- parts of gastrodia elata, 8-15 parts of angelica sinensis, 8-15 parts of taxillus chinensis, 8-30 parts of millettia dielsiana.
2. A formula for treating cardiovascular and cerebrovascular diseases according to claim 1, wherein it comprises the following ingredients in parts by weight: 8 parts of ginseng, 15 parts of astragalus, 8 parts of atractylodes, 8 parts of poria, 15 parts of cistanche, 8 parts of epimedium, 8 parts of rehmannia, 10 parts of tortoises shell, 8 parts of turtle shell, 8 parts of concha haliotidis, 8 parts of prunella vulgaris, 1 part of resina draconis, 6 parts of rhizoma corydalis, 3 parts of olibanum, 3 parts of myrrha, 8 parts of chuanxiong rhizome, 8 parts of panax notoginseng, 2 parts of scorpion, 8 parts of lumbricus, 2 parts of centipede, 8 parts of bombyx batryticatus, 8 parts of seaweed, 6 parts of fructus trichosanthis, 10 parts of rhizoma cyperi, 5 parts of radix aucklandiae, 8 parts of uncaria, 8 parts of gastrodia elata, 8 parts of angelica sinensis, 8 parts of taxillus chinensis, 8 parts of millettia dielsiana.
3. A formula for treating cardiovascular and cerebrovascular diseases according to claim 1, wherein it comprises the following ingredients in parts by weight: 20 parts of ginseng, 60 parts of astragalus, 15 parts of atractylodes, 15 parts of poria, 30 parts of cistanche, 20 parts of epimedium, 15 parts of rehmannia, 30 parts of tortoises shell, 25 parts of turtle shell, 30 parts of concha haliotidis, parts of prunella vulgaris, 5 parts of resina draconis, 15 parts of rhizoma corydalis, 10 parts of olibanum, 10 parts of myrrha, 20 parts of chuanxiong rhizome, 15 parts of panax notoginseng, 8 8
BL-5579 parts of scorpion, 15 parts of lumbricus, 5 parts of centipede, 20 parts of bombyx batryticatu&/5D2953 parts of seaweed, 20 parts of fructus trichosanthis, 30 parts of rhizoma cyperi, 10 parts of radix aucklandiae, 25 parts of uncaria, 15 parts of gastrodia elata, 15 parts of angelica sinensis, 15 parts of taxillus chinensis, 30 parts of millettia dielsiana.
4. A formula for treating cardiovascular and cerebrovascular diseases according to claim 1, wherein it comprises the following ingredients in parts by weight: 14 parts of ginseng, 35 parts of astragalus, 12 parts of atractylodes, 12 parts of poria, 22 parts of cistanche, 14 parts of epimedium, 11 parts of rehmannia, 20 parts of tortoises shell, 13 parts of turtle shell, 19 parts of concha haliotidis, 14 parts of prunella vulgaris, 3 parts of resina draconis, 11 parts of rhizoma corydalis, 6.5 parts of olibanum, 6.5 parts of myrrha, 14 parts of chuanxiong rhizome, 11 parts of panax notoginseng, 5 parts of scorpion, 11 parts of lumbricus, 3.5 parts of centipede, 14 parts of bombyx batryticatus, 11 parts of seaweed, 13 parts of fructus trichosanthis, 20 parts of rhizoma cyperi, 7.5 parts of radix aucklandiae, 13 parts of uncaria, 13 parts of gastrodia elata, 12 parts of angelica sinensis, 13 parts of taxillus chinensis, 19 parts of millettia dielsiana.
5. A preparation method of a formula for treating cardiovascular and cerebrovascular diseases, wherein the formula is the formula according to any one of claims 1-4, and comprises the following preparation process: take a certain amount of ginseng, astragalus, atractylodes, poria, cistanche, epimedium, rehmannia, tortoises shell, turtle shell, concha haliotidis, prunella vulgaris, resina draconis, rhizoma corydalis, olibanum, myrrha, chuanxiong rhizome, panax notoginseng, scorpion, lumbricus, centipede, bombyx batryticatus, seaweed, fructus trichosanthis, rhizoma cyperi, radix aucklandiae, uncaria, gastrodia elata, angelica sinensis, taxillus chinensis, and millettia dielsiana are mixed, then use grinding equipment to grind them into a certain fineness of powder, and then add honey and mix to make pills.
6. The preparation method of the formula according to claim 5, wherein the grinding fineness of the powder is 50-100 mesh. 9
LU502953A 2022-10-25 2022-10-25 A formula for treating cardiovascular and cerebrovascular diseases and preparation method thereof LU502953B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
LU502953A LU502953B1 (en) 2022-10-25 2022-10-25 A formula for treating cardiovascular and cerebrovascular diseases and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU502953A LU502953B1 (en) 2022-10-25 2022-10-25 A formula for treating cardiovascular and cerebrovascular diseases and preparation method thereof

Publications (1)

Publication Number Publication Date
LU502953B1 true LU502953B1 (en) 2023-04-27

Family

ID=86097385

Family Applications (1)

Application Number Title Priority Date Filing Date
LU502953A LU502953B1 (en) 2022-10-25 2022-10-25 A formula for treating cardiovascular and cerebrovascular diseases and preparation method thereof

Country Status (1)

Country Link
LU (1) LU502953B1 (en)

Similar Documents

Publication Publication Date Title
CN101461921B (en) Medicinal composition for treating gynecopathy
CN102274361A (en) Anticancer medicinal composition and preparation method of decoction thereof
CN105055606A (en) Medicine for treating influenza
CN105012720A (en) Traditional Chinese medicine composition for treating osteopathy
CN113813347A (en) Preparation method and process of compound paclitaxel anti-tumor capsule tablet
CN115837065B (en) Traditional Chinese medicine composition and application thereof
LU502953B1 (en) A formula for treating cardiovascular and cerebrovascular diseases and preparation method thereof
CN105796845A (en) Application of medicine composition in preparing medicine for treating female climacteric syndromes
CN105012893A (en) Traditional Chinese medicine composition for treating coronary heart disease
CN115252753A (en) Traditional Chinese medicine composition for treating insomnia and application thereof
CN104984296A (en) Pharmaceutical composition for treating female climacteric syndrome and preparation method thereof
CN106581299B (en) Traditional Chinese medicine composition for improving kidney qi deficiency of middle-aged and old people and application thereof
CN102293985A (en) Traditional Chinese medicine composition used for treating coronary heart disease and preparation method thereof
CN105362630A (en) Climacteric syndrome treatment pharmaceutical composition and preparation method thereof
CN105169338A (en) Medicine composition for treating female climacteric syndromes and preparation method thereof
CN108635457A (en) A kind of Chinese medicine composition and the preparation method and application thereof for treating constipation
CN111388564B (en) Traditional Chinese medicine for treating bradyarrhythmia
CN113599463A (en) Formula for treating cardiovascular and cerebrovascular diseases and preparation method thereof
CN101983712A (en) Novel medicament for treating coronary heart disease
CN109793846B (en) A Chinese medicinal composition
CN106943506B (en) A pharmaceutical composition for treating climacteric syndrome, and its preparation method
CN1359702A (en) Formula and production process of supplement
CN105412768A (en) Medicine composition for treating infertility and preparation method thereof
CN105079438A (en) Pharmaceutic preparation for treating viral myocarditis
CN111388578A (en) Traditional Chinese medicine composition for treating facial paralysis as well as preparation and application thereof

Legal Events

Date Code Title Description
FG Patent granted

Effective date: 20230427